Compounds > aripiprazole
Page last updated: 2024-08-24

aripiprazole and n-(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamide

aripiprazole has been researched along with n-(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bojarski, AJ; Lacivita, E; Leopoldo, M; Niso, M; Perrone, R; Perrone-Capano, C; Podlewska, S; Satała, G; Speranza, L1

Other Studies

1 other study(ies) available for aripiprazole and n-(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamide

ArticleYear
Structural modifications of the serotonin 5-HT7 receptor agonist N-(4-cyanophenylmethyl)-4-(2-biphenyl)-1-piperazinehexanamide (LP-211) to improve in vitro microsomal stability: A case study.
    European journal of medicinal chemistry, 2016, Sep-14, Volume: 120

    Topics: Animals; Blood-Brain Barrier; Drug Design; Drug Stability; Mice; Microsomes; Piperazines; Receptors, Serotonin; Serotonin Receptor Agonists

2016